ASAH1-related sphingolipidosis

MONDO:0100524

A spectrum of disorders caused by variation(s) in the ASAH1 genel this spectrum includes Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy. The ASAH1 gene encodes the lysosomal hydrolase that breaks down the bioactive lipid, ceramide.

Also known as: ASAH1-related disorders, ASAH1-related sphingolipidosis, acid ceramidase deficiency

36 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Sub-types

Broader categories

Sort by